► Eptifibatide is associated with profound thrombocytopenia and thrombosis secondary to a HITT-like mechanism associated with drug-dependant antibodies. ► Caution with eptifibatide use is needed in those pre-disposed to hypercoaguability, particularly those with an underlying malignancy.
Squires, K. C., Guntupalli, S. R., & Thaker, P. H. (2012). Eptifibatide induced profound thrombocytopenia in a patient with pelvic malignancy: A case report. Gynecologic Oncology Reports, 2(3), 75–77. https://doi.org/10.1016/j.gynor.2012.03.002